Betta Pharmaceuticals Co., Ltd. (SHE: 300558)
China flag China · Delayed Price · Currency is CNY
47.39
-1.12 (-2.31%)
Nov 15, 2024, 3:04 PM CST

Betta Pharmaceuticals Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Jan '22 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
595.34752731.28791.991,346521.3
Upgrade
Short-Term Investments
----190-
Upgrade
Trading Asset Securities
221.040.54-201.01--
Upgrade
Cash & Short-Term Investments
816.38752.54731.289931,536521.3
Upgrade
Cash Growth
17.58%2.91%-26.36%-35.35%194.64%70.93%
Upgrade
Accounts Receivable
228.3286.41450.62173.3852.6156.03
Upgrade
Other Receivables
1.772.6149.740.756.811.64
Upgrade
Receivables
230.07289.02500.32214.1359.4257.67
Upgrade
Inventory
289.09327.5372.17293.32188.59134.57
Upgrade
Prepaid Expenses
-0.2----
Upgrade
Other Current Assets
191.03156.62129.06153.4963.9178.7
Upgrade
Total Current Assets
1,5271,5261,7331,6541,848792.24
Upgrade
Property, Plant & Equipment
2,8372,5742,0561,331775.72789.92
Upgrade
Long-Term Investments
1,3561,382919.27345.79274.55118.72
Upgrade
Goodwill
413.58413.58413.58413.58413.58427.45
Upgrade
Other Intangible Assets
1,7831,9441,2191,183603.37486.19
Upgrade
Long-Term Deferred Tax Assets
38.9439.1385.9655.0655.2229.49
Upgrade
Long-Term Deferred Charges
1,3711,2191,4441,2521,171913.07
Upgrade
Other Long-Term Assets
32.6450.339.337.687.79576.24
Upgrade
Total Assets
9,3589,1477,9106,2715,2304,133
Upgrade
Accounts Payable
712.5310.6735.85431.19113.6229.25
Upgrade
Accrued Expenses
133.38268.86419.11357.02187.53164.56
Upgrade
Short-Term Debt
111.08300.27380.39--363.23
Upgrade
Current Portion of Long-Term Debt
565.96301.25----
Upgrade
Current Portion of Leases
-4.64.164.88--
Upgrade
Current Income Taxes Payable
16.370.070.0410.6827.5411.03
Upgrade
Current Unearned Revenue
1.754.924.460.691.2748.73
Upgrade
Other Current Liabilities
235.83912.511,26184.4108.1488.39
Upgrade
Total Current Liabilities
1,7771,8032,105888.86438.1705.2
Upgrade
Long-Term Debt
1,6451,816656.03-2.6280
Upgrade
Long-Term Leases
6.148.187.36.34--
Upgrade
Long-Term Unearned Revenue
154.31144.7112.7611258.0157.77
Upgrade
Long-Term Deferred Tax Liabilities
49.0323.3971.5768.3964.6463.05
Upgrade
Other Long-Term Liabilities
---510.06521.99558.1
Upgrade
Total Liabilities
3,6323,7952,9521,5861,0851,664
Upgrade
Common Stock
418.49418.49417.47415.39413.16401
Upgrade
Additional Paid-In Capital
2,2151,9451,8601,9321,793654.87
Upgrade
Retained Earnings
2,8482,5032,1812,1391,8831,353
Upgrade
Comprehensive Income & Other
156.15384.48390.9974.6452.2851.94
Upgrade
Total Common Equity
5,6375,2514,8494,5614,1412,461
Upgrade
Minority Interest
89.16100.4108.64124.93.418.68
Upgrade
Shareholders' Equity
5,7265,3514,9584,6864,1442,469
Upgrade
Total Liabilities & Equity
9,3589,1477,9106,2715,2304,133
Upgrade
Total Debt
2,3292,4301,04811.222.6643.23
Upgrade
Net Cash (Debt)
-1,512-1,678-316.59981.771,533-121.94
Upgrade
Net Cash Growth
----35.97%--
Upgrade
Net Cash Per Share
-3.57-3.99-0.762.363.77-0.30
Upgrade
Filing Date Shares Outstanding
418.49418.49417.47415.39413.16401
Upgrade
Total Common Shares Outstanding
418.49418.49417.47415.39413.16401
Upgrade
Working Capital
-250.33-277.28-371.95765.081,41087.04
Upgrade
Book Value Per Share
13.4712.5511.6210.9810.026.14
Upgrade
Tangible Book Value
3,4412,8943,2162,9643,1241,547
Upgrade
Tangible Book Value Per Share
8.226.927.707.147.563.86
Upgrade
Buildings
-586.14585.59627.19588.32591.46
Upgrade
Machinery
-424.26402.25376.01339.24240.06
Upgrade
Construction In Progress
-2,0371,448639.6763.12112.31
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.